Abstract
Solid tumors contain regions of chronic and cyclic hypoxia. Chronic hypoxia can downregulate RAD51 and sensitize cells to PARP inhibition. Herein, we show that RAD51 expression, cell survival and toxicity to PARP inhibition is not affected under cyclic hypoxic conditions. This suggests that PARP inhibition may be selectively toxic in tumor sub-regions associated with chronic hypoxia.
Original language | English |
---|---|
Pages (from-to) | 388-391 |
Number of pages | 4 |
Journal | Radiotherapy and Oncology |
Volume | 116 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Sept 2015 |
Keywords
- Cyclic hypoxia
- DNA repair
- PARP inhibition
- RAD51
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre